Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy C Luo, J Sun, D Liu, B Sun, L Miao, S Musetti, J Li, X Han, Y Du, L Li, ... Nano letters 16 (9), 5401-5408, 2016 | 369 | 2016 |
Combination immunotherapy of MUC1 mRNA nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast cancer L Liu, Y Wang, L Miao, Q Liu, S Musetti, J Li, L Huang Molecular Therapy 26 (1), 45-55, 2018 | 290 | 2018 |
Nanomaterials for cancer immunotherapy W Song, SN Musetti, L Huang Biomaterials 148, 16-30, 2017 | 261 | 2017 |
Nanoparticle-mediated remodeling of the tumor microenvironment to enhance immunotherapy S Musetti, L Huang ACS nano 12 (12), 11740-11755, 2018 | 195 | 2018 |
Biomolecule-assisted green synthesis of nanostructured calcium phosphates and their biomedical applications C Qi, S Musetti, LH Fu, YJ Zhu, L Huang Chemical Society Reviews 48 (10), 2698-2737, 2019 | 151 | 2019 |
Local and transient gene expression primes the liver to resist cancer metastasis TJ Goodwin, Y Zhou, SN Musetti, R Liu, L Huang Science translational medicine 8 (364), 364ra153-364ra153, 2016 | 81 | 2016 |
A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA C Luo, L Miao, Y Zhao, S Musetti, Y Wang, K Shi, L Huang Biomaterials 102, 239-248, 2016 | 70 | 2016 |
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma Q Liu, H Zhu, Y Liu, S Musetti, L Huang Cancer Immunology, Immunotherapy 67, 299-310, 2018 | 64 | 2018 |
Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers Y Wang, Y Zhao, Y Cui, Q Zhao, Q Zhang, S Musetti, KA Kinghorn, ... Acta Biomaterialia 65, 405-416, 2018 | 51 | 2018 |
RNA interference-based cancer drugs: The roadblocks, and the “delivery” of the promise M Das, S Musetti, L Huang Nucleic acid therapeutics 29 (2), 61-66, 2019 | 39 | 2019 |
Dual functional lipomet mediates envelope-type nanoparticles to combinational oncogene silencing and tumor growth inhibition K Shi, Y Zhao, L Miao, A Satterlee, M Haynes, C Luo, S Musetti, L Huang Molecular Therapy 25 (7), 1567-1579, 2017 | 28 | 2017 |
Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy H Zhu, Q Liu, L Miao, S Musetti, M Huo, L Huang Nanoscale 12 (5), 3400-3410, 2020 | 24 | 2020 |
Nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy C Luo, J Sun, D Liu, B Sun, L Miao, S Musetti, J Li, X Han, Y Du, L Li, ... Nano Lett 16 (9), 5401-5408, 2016 | 8 | 2016 |
Tinagl1 gene therapy suppresses growth and remodels the microenvironment of triple negative breast cancer SN Musetti, L Huang Molecular Pharmaceutics 18 (5), 2032-2038, 2021 | 6 | 2021 |
Oral metformin and polymetformin reprogram immunosuppressive microenvironment and boost immune checkpoint inhibitor therapy in colorectal cancer Y Xiong, W Song, L Shen, Y Wang, J Zhang, M Hu, Y Liu, J Li, S Musetti, ... Advanced Therapeutics 3 (12), 2000168, 2020 | 5 | 2020 |
Erratum to" Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers"[Acta Biomater. 65 (2017) 405-416] Y Wang, Y Zhao, Y Cui, Q Zhao, Q Zhang, S Musetti, KA Kinghorn, ... Acta biomaterialia 72, 462-463, 2018 | 2 | 2018 |
Gene Therapy with Plasmid DNA Y Liu, S Musetti, L Huang Burger's Medicinal Chemistry and Drug Discovery, 1-35, 2003 | 2 | 2003 |
Remodeling the Tumor Microenvironment of Triple Negative Breast Cancer with Novel Nanoformulations S Musetti The University of North Carolina at Chapel Hill, 2021 | | 2021 |
Tinagl1 gene therapy for tumor-wide remodeling of triple negative breast cancer S Musetti, H Leaf European Journal of Cancer 138, S37-S38, 2020 | | 2020 |
Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers (vol 65, pg 405, 2017) Y Wang, Y Zhao, Y Cui, Q Zhao, Q Zhang, S Musetti, KA Kinghorn, ... ACTA BIOMATERIALIA 72, 462-463, 2018 | | 2018 |